Researchers from Vienna University of Technology (TU Wien), Austria, have used chip capillary electrophoresis (CE) in combination with molecular beacons (MBs) to analyze the release of the RNA genome from a human rhinovirus.
Photo Credit: Laguna Design/Getty Images
Researchers from Vienna University of Technology (TU Wien), Austria, have used chip capillary electrophoresis (CE) in combination with molecular beacons (MBs) to analyze the release of the RNA genome from a human rhinovirus.1
Human rhinoviruses (HRVs), the virus family responsible for the common cold, are problematic because of their proficiency to cause discomfort and also the significant challenges they present to researchers to analyze. Measuring only 30 nm in diameter,2 the non-enveloped, icosahedral particles are not easily visualized or characterized, with 160 serotypes identified to date. These factors have contributed to considerable knowledge gaps surrounding the basic functioning of these very common viruses.
“The exact mechanism of RNA release from a rhinovirus in vivo from inside the protective virus capsid and through the lipid membrane of endosomes is at the moment still not completely understood,” said Günter Allmaier, TU Wien, Austria.
This is an incredibly important step in the virus’s replication process and understanding it could lead to potential targets for medical interventions. Viruses have no reproduction capability of their own, instead they utilize a host cell’s own apparatus to replicate. In order to achieve this, they must introduce their own genetic material into the cell and part of this process involves that RNA passing through the viral capsid (shell).3 Preventing this transfer of RNA and therefore virus replication would eliminate the virus.
The challenge for researchers was to develop a methodology capable of analyzing the release of viral RNA from the protective capsid and open the process up to future more inâdepth research.
The method developed uses molecular beacons (MBs), which “are oligonucleotide probes modified by a fluorophore and a fluorescence quencher at their 3’ and 5’ ends. In the absence of a complementary DNA or RNA target sequence, the terminal nucleotides of a molecular beacon form a helix stem. This in turn leads to spatial proximity between the attached fluorophore and quencher resulting in only very low intensity fluorescence. However, in the presence of a respective target, the molecular beacon hybridizes to the target, the stem opens up and an increase in fluorescence is recorded,” explained Weiss and Allmaier.
Through this fast, sensitive, and easyâtoâuse lab-on-a-chip-based method, Allmaier and his team can specifically detect the genome release using fluorescence detection after the sample components have been separated by chip CE. Thereby successfully setting the stage for further investigation into the mode of release of the RNA genome of a human rhinovirus.
The TU Wien team also hope the method could be adapted to other areas, including the investigation of gene therapy delivery systems and RNA release control.
References
Look out for the interview with Günter Allmaier on this research in the next issue of The Column.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.